Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus
Hiroaki Uchida(Tokyo University of Pharmacy and Life Sciences), Joseph C. Glorioso(University of Pittsburgh), Marco Marzulli(University of Pittsburgh), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Hyunjung Baek(Korea Institute of Radiological and Medical Sciences), E. Antonio Chiocca(Center for Cancer Research), Balveen Kaur(Augusta University), William F. Goins(University of Pittsburgh), Kenji Nakano(National Center for Global Health and Medicine), Hiroshi Nakashima(Brigham and Women's Hospital), Amy Haseley(Neurological Surgery), Justus B. Cohen(University of Pittsburgh), Heechung Kwon(Korea Institute of Radiological and Medical Sciences), Paola Grandi(University of Pittsburgh), Masahide Kuroki(Fukuoka University), Janet Chan(University of Pittsburgh), Lucia Mazzacurati(Molecular Oncology (United States)), Chang‐Sook Hong(University of Pittsburgh), Izumi Kumagai(Tokyo University of Agriculture and Technology)
Cited by 117
Related Papers
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.5k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Decreased extra-renal urate excretion is a common cause of hyperuricemia
|Nature Communications|2012|703
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
|Science Advances|2018|614
Multiplexed Profiling of Single Extracellular Vesicles
|ACS Nano|2017|372